Study: COVID-19: Azelastine nasal spray Reduces Virus-load In Nasal swabs (CARVIN) Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients – results ...

According to IQVIA, U.S. sales of Azelastine Hydrochloride Nasal Spray, 0.1% were approximately $46 million for the twelve months ended March 2019. Azelastine Hydrochloride Nasal Spray, 0.1% is ...

Padagis has announced the approval of a generic over-the-counter (OTC) naloxone hydrochloride nasal spray, a therapeutically equivalent version of Narcan ® nasal spray. Naloxone hydrochloride ...

Monica Torres Thu, June 15, 2023 at 9:45 AM UTC 4 min read ...

According to a release from Amneal Pharmaceuticals Inc., approval means the USP 4 mg formulation, a generic equivalent to OTC Narcan HCI nasal spray, can be purchased over the counter.

The global market for Inhalation and Nasal Spray Generic Drugs was estimated at US$34.8 Billion in 2023 and is projected to reach US$50.3 Billion by 2030, growing at a CAGR of 5.4% from 2023 to 2030.

Hsu S, Stevens D, Sajjad F, Salapatek A. Onset of action of azelastine HCl nasal spray 0.15% evaluated in an environmental exposure chamber. Ann Allergy Asthma Immunol. 2022;125 (5):S71. doi:10. ...

ALLEGAN, Mich., Nov. 16, 2021 /PRNewswire/ -- Padagis today announced the first-to-market launch of an AB-rated generic version of Zomig® Nasal Spray.

The FDA approved Astepro (azelastine hydrochloride nasal spray, 0.15%) for seasonal and perennial allergic rhinitis—commonly known as allergies—for adults and children six years of age and older.

The US Food and Drug Administration (FDA) has approved one formulation of azelastine (Astepro) nasal spray for nonprescription treatment of allergies, making it the first nasal antihistamine ...